These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16272734)

  • 41. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord.
    Tegeder I; Niederberger E; Vetter G; Bräutigam L; Geisslinger G
    J Neurochem; 2001 Nov; 79(4):777-86. PubMed ID: 11723170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells.
    Lee SJ; Lee IS; Mar W
    Arch Pharm Res; 2003 Oct; 26(10):832-9. PubMed ID: 14609132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparative isolation and purification of two phenylbutenoids from the rhizomes of Zingiber cassumunar by upright counter-current chromatography.
    Lu Y; Sun C; Wang Y; Pan Y
    J Chromatogr A; 2005 Sep; 1089(1-2):258-62. PubMed ID: 16130795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel compounds from Piper methysticum Forst (Kava Kava) roots and their effect on cyclooxygenase enzyme.
    Wu D; Nair MG; DeWitt DL
    J Agric Food Chem; 2002 Feb; 50(4):701-5. PubMed ID: 11829631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
    Wang K; Tarakji K; Zhou Z; Zhang M; Forudi F; Zhou X; Koki AT; Smith ME; Keller BT; Topol EJ; Lincoff AM; Penn MS
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):61-7. PubMed ID: 15613981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
    Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
    Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
    Pinheiro RM; Calixto JB
    Inflamm Res; 2002 Dec; 51(12):603-10. PubMed ID: 12558194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hidden mechanism beyond ginger (Zingiber officinale Rosc.) potent in vivo and in vitro anti-inflammatory activity.
    Ezzat SM; Ezzat MI; Okba MM; Menze ET; Abdel-Naim AB
    J Ethnopharmacol; 2018 Mar; 214():113-123. PubMed ID: 29253614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phytochemicals and Bioactivities of
    Han AR; Kim H; Piao D; Jung CH; Seo EK
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921835
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro.
    Igarashi K; Woo JT; Stern PH
    Biochem Pharmacol; 2002 Feb; 63(3):523-32. PubMed ID: 11853703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual inhibitory effects of furonaphthoquinone compound on enzyme activity and lipopolysaccharide-induced expression of cyclooxygenase-2 in macrophages.
    Ahn KY; Kim BH; Lee YR; Hwang DH; Chung EY; Min KR; Kim Y
    Biochem Biophys Res Commun; 2005 Oct; 336(1):93-9. PubMed ID: 16125137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest.
    Han C; Leng J; Demetris AJ; Wu T
    Cancer Res; 2004 Feb; 64(4):1369-76. PubMed ID: 14973068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two new diterpenoids from the rhizomes of
    Zhou M; Li T; Zeng C; Pan DB; Li HB; Yu Y
    Nat Prod Res; 2023 Jul; 37(13):2255-2262. PubMed ID: 35184622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
    Longo WE; Panesar N; Mazuski J; Kaminski DL
    Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):325-39. PubMed ID: 9990676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.